RECRUITINGNCT07894185Liège, BelgiumContactsSMAdult - Monitoring of Movement on Spinal Muscular AtrophyUpdated: Oct 26, 2026
RECRUITINGNCT078888683 locationsService Evaluation for Newborn Screening for Spinal Muscular AtrophyUpdated: Oct 22, 2026
RECRUITINGNCT078836553 locationsContactsAdvanced Multi-omics and -System Approaches to Identify Novel Biomarkers for SMAUpdated: Oct 20, 2026
RECRUITINGNCT07822711Beijing, ChinaContactsEffects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMAUpdated: Oct 23, 2026
RECRUITINGNCT07805278Memphis, United StatesContactsA Registry of Cases of Spinal Muscular AtrophyUpdated: Oct 22, 2026
RECRUITINGNCT077678904 locationsContactsA Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy PatientsUpdated: Oct 22, 2026
RECRUITINGNCT075549243 locationsContactsA Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type IUpdated: Oct 14, 2026
RECRUITINGNCT07543003Oxford, United KingdomContactsAn International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)Updated: May 11, 2026
RECRUITINGNCT07531719Cairo, EgyptContactsA Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)Updated: Oct 2, 2026
RECRUITINGNCT07521930Baltimore, United StatesContactsInterfacing With NeuroTechnology to Expand Neural Throughput (INTENT)Updated: Oct 9, 2026
RECRUITINGNCT07488338New York, United StatesContactsHABIT-ILE + FST in Children With SMA: Preliminary EffectivenessUpdated: Oct 22, 2026
RECRUITINGNCT07478172Columbia, United StatesContactsEffects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular DiseaseUpdated: Mar 17, 2026
RECRUITINGNCT07467187Copenhagen, DenmarkContactsInvasive Home Ventilation in DenmarkUpdated: Apr 20, 2026
RECRUITINGNCT07448610New York, United StatesContactsASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)Updated: Sep 18, 2026
RECRUITINGNCT074444763 locationsContactsA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamUpdated: Oct 2, 2026
RECRUITINGNCT07444450Flower Mound, United StatesContactsA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene AbeparvovecUpdated: Oct 15, 2026
RECRUITINGNCT07332702Rouen, FranceContactsLong Read Analysis in Spinal Muscular Atrophy - LOREASIUpdated: Jan 12, 2026
RECRUITINGNCT07321977Paris, FranceContactsAssessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic VolunteersUpdated: May 19, 2026
RECRUITINGNCT0728798228 locationsContactsA Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular AtrophyUpdated: Oct 8, 2026